Document is current
Any future updates will be listed below
-
Authors
Root, James C. https://orcid.org/0000-0001-7332-6165
Zhou, Xingtao
Ahn, Jaeil
Small, Brent J.
Zhai, Wanting
Bethea, Traci
Carroll, Judith E.
Cohen, Harvey Jay
Dilawari, Asma
Extermann, Martine
Graham, Deena
Isaacs, Claudine
Jacobsen, Paul B.
Jim, Heather
McDonald, Brenna C.
Nakamura, Zev M.
Patel, Sunita K.
Rentscher, Kelly
Saykin, Andrew J.
Van Dyk, Kathleen
Mandelblatt, Jeanne S.
Ahles, Tim A.
-
Funding
Funding for this research was provided by:
National Cancer Institute (R01CA129769)
National Cancer Institute (R35CA197289)
National Cancer Institute (P30CA51008)
National Institutes of Health (P30AG10133)
National Institutes of Health (R01AG19771)
National Institutes of Health (R01LM01136)
National Institutes of Health (R01CA244673)
National Institutes of Health (R01CA218496)
National Institutes of Health (R01CA172119)
National Institutes of Health (R03CA249548)
National Institutes of Health (P30CA008748)
National Institutes of Health (R01CA237535)
National Institutes of Health (P30AG028716)
American Cancer Society (128660-RSG-15-187-01-PCSM)
American Cancer Society (RSG-17-023-01-CPPB)
- License Information
-
More Information
Article History
Received: 11 April 2022
Accepted: 30 April 2022
First Online: 19 May 2022
Declarations
:
: Asma Dilawari has served on the Cardinal Health oncology summit advisor board, 2019. Claudine Isaacs has served as a consultant for Genentech, Seattle Genetics, PUMA, Novartis, AstraZeneca, Sanofi, and Pfizer, and received support for research (to institution) from Pfizer and Tesaro/GSK. Heather Jim has consulted for RedHill BioPharma, Janssen Scientific Affairs, and Merck, and has received grant funding from Kite Pharma. The other authors declare that they have no conflict of interest.
: Informed consent was obtained from all individual participants included in the study.
: The authors affirm that human research participants provided informed consent for publication.
: The content is solely the responsibility of the authors and does not represent the official views of the National Institutes of Health.
: This Institutional Review Board-approved study (ClinicalTrials.gov Identifier: NCT03451383) has been reported previously [, ] and was conducted at six US sites in Los Angeles, New York City, New Jersey, the DC metropolitan area, Indianapolis, and Tampa.
: The funders had no role in the design of the study; the collection, analysis, and interpretation of the data; the writing of the manuscript; and the decision to submit the manuscript for publication.
